Reshma Kewalramani insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Reshma reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | VRTX | ↓ Sell | 40,000 | $493.47 | $19.7M | Direct | Mar 3, 2026 (4d) |
| Aug 6, 2025 | VRTX | ↑ Buy | 10,000 | $389.58 | $3.9M | Direct | Aug 7, 2025 (1d) |
| Nov 8, 2024 | VRTX | ↓ Sell | 15,198 | $515.00 | $7.8M | Direct | Nov 12, 2024 (4d) |
| Jul 30, 2024 | VRTX | ↓ Sell | 15,202 | $505.00 | $7.7M | Direct | Aug 1, 2024 (2d) |
| Jul 22, 2024 | VRTX | ↓ Sell | 15,202 | $497.00 | $7.6M | Direct | Jul 24, 2024 (2d) |
| May 24, 2024 | VRTX | ↓ Sell | 1,565 | $457.00 | $715K | Direct | May 29, 2024 (5d) |
| May 20, 2024 | VRTX | ↓ Sell | 15,202 | $447.00 | $6.8M | Direct | May 22, 2024 (2d) |
| Dec 15, 2023 | VRTX | ↓ Sell | 17,135 | $407.00 | $7.0M | Direct | Dec 19, 2023 (4d) |
| Dec 13, 2023 | VRTX | ↓ Sell | 5,098 | $397.00 | $2.0M | Direct | Dec 15, 2023 (2d) |
| Nov 13, 2023 | VRTX | ↓ Sell | 5,097 | $377.00 | $1.9M | Direct | Nov 15, 2023 (2d) |
| Jul 17, 2023 | VRTX | ↓ Sell | 7,828 | $355.00 | $2.8M | Direct | Jul 18, 2023 (1d) |
| Apr 27, 2023 | VRTX | ↓ Sell | 3,317 | $339.08 | $1.1M | Direct | May 1, 2023 (4d) |
| Jan 25, 2023 | VRTX | ↓ Sell | 10,000 | $315.05 | $3.2M | Direct | Jan 27, 2023 (2d) |
| Aug 15, 2022 | VRTX | ↓ Sell | 11,689 | $305.06 | $3.6M | Direct | Aug 17, 2022 (2d) |
| Jun 24, 2022 | VRTX | ↓ Sell | 11,689 | $291.30 | $3.4M | Direct | Jun 28, 2022 (4d) |
| Aug 19, 2021 | VRTX | ↑ Buy | 10,000 | $195.65 | $2.0M | Direct | Aug 23, 2021 (4d) |
| Aug 6, 2020 | VRTX | ↓ Sell | 2,073 | $271.20 | $562K | Direct | Aug 10, 2020 (4d) |
| May 15, 2020 | VRTX | ↓ Sell | 99 | $284.17 | $28K | Direct | May 19, 2020 (4d) |
| May 6, 2020 | VRTX | ↓ Sell | 2,074 | $272.85 | $566K | Direct | May 8, 2020 (2d) |
| Feb 25, 2020 | VRTX | ↓ Sell | 3,634 | $233.45 | $848K | Direct | Feb 26, 2020 (1d) |
| Feb 18, 2020 | VRTX | ↓ Sell | 1,183 | $243.51 | $288K | Direct | Feb 19, 2020 (1d) |
| Feb 6, 2020 | VRTX | ↓ Sell | 2,074 | $239.44 | $497K | Direct | Feb 7, 2020 (1d) |
| Nov 25, 2019 | VRTX | ↓ Sell | 4,692 | $219.37 | $1.0M | Direct | Nov 26, 2019 (1d) |
| Nov 15, 2019 | VRTX | ↓ Sell | 61 | $205.95 | $13K | Direct | Nov 19, 2019 (4d) |
| Nov 8, 2019 | VRTX | ↓ Sell | 509 | $199.00 | $101K | Direct | Nov 13, 2019 (5d) |
| Oct 30, 2019 | VRTX | ↓ Sell | 3,057 | $199.00 | $608K | Direct | Oct 31, 2019 (1d) |
| Oct 22, 2019 | VRTX | ↓ Sell | 638 | $189.00 | $121K | Direct | Oct 24, 2019 (2d) |
| May 15, 2019 | VRTX | ↓ Sell | 241 | $165.41 | $40K | Direct | May 17, 2019 (2d) |
| Feb 19, 2019 | VRTX | ↓ Sell | 1,488 | $186.94 | $278K | Direct | Feb 21, 2019 (2d) |
| Oct 8, 2018 | VRTX | ↓ Sell | 2,305 | $186.95 | $431K | Direct | Oct 9, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Reshma Kewalramani's insider trades
Reshma Kewalramani is CEO & President at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Oct 8, 2018, Reshma has reported 2 open-market purchases worth $5.9M and 28 sales worth $80.7M on SEC Form 4. In the last 12 months: 1 sale ($19.7M).
Their filings also include shares withheld for taxes (22 filings), grants and awards (13 filings), option exercises (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.

